Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis

10.1016/j.ijid.2018.05.017International Journal of Infectious Diseases7648-5

Clinical experience with high-dose polymyxin b against carbapenem-resistant gram-negative bacterial infections—a cohort study

10.3390/antibiotics9080451Antibiotics981-1

Prospective audit and feedback in antimicrobial stewardship: Is there value in early reviewing within 48 h of antibiotic prescription?

10.1016/j.ijantimicag.2014.10.018International Journal of Antimicrobial Agents452168-17

Using an adenosine triphosphate bioluminescent assay to determine effective antibiotic combinations against carbapenem-resistant gram negative bacteria within 24 hours

10.1371/journal.pone.0140446PLoS ONE1010e014044

Elimination of extracellular adenosine triphosphate for the rapid prediction of quantitative plate counts in 24 H time-kill studies against carbapenem-resistant gram-negative bacteria

10.3390/microorganisms8101489Microorganisms8101-1

From Bench-Top to Bedside: A prospective In vitro Antibiotic Combination Testing (iACT) service to guide the selection of rationally optimized antimicrobial combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)

10.1371/journal.pone.0158740PLoS ONE117e015874

Correction: Candidemia in a major regional tertiary referral hospital - Epidemiology, practice patterns and outcomes (Antimicrobial Resistance and Infection Control (2017) 6 (27) DOI: 10.1186/s13756-017-0184-1)

10.1186/s13756-018-0413-2Antimicrobial Resistance and Infection Control7

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections

10.2147/IDR.S168191Infection and Drug Resistance1

Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes

10.1186/s13756-017-0184-1Antimicrobial Resistance and Infection Control612

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.

To evaluate antibody specificities induced by simian immunodeficiency virus (SIV) versus human immunodeficiency virus type 1 (HIV-1) envelope antigens in nonhuman primate (NHP), we profiled binding antibody responses to linear epitopes in NHP studies with HIV-1 or SIV immunogens. We found that, overall, HIV-1 Env IgG responses were dominated by V3, with the notable exception of the responses to the vaccine strain A244 Env that were dominated by V2, whereas the anti-SIVmac239 Env responses were dominated by V2 regardless of the vaccine regimen